» Articles » PMID: 19747933

Effect of Kappa-opioid Receptor Agonists U69593, U50488H, Spiradoline and Salvinorin A on Cocaine-induced Drug-seeking in Rats

Overview
Publisher Elsevier
Date 2009 Sep 15
PMID 19747933
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous work indicated that pretreatment with the selective kappa-opioid receptor (KOPr) agonist, U69593, attenuated the ability of priming injections of cocaine to reinstate extinguished cocaine-seeking behavior. The present study expanded these initial tests to include other traditional KOPr agonists, U50488H, spiradoline (SPR), and salvinorin A (Sal A), an active constituent of the plant Salvia divinorum. Following acquisition and stabilization of cocaine self-administration, cocaine-produced drug-seeking was measured. This test was conducted in a single day and comprised an initial phase of self-administration, followed by a phase of extinguished responding. The final phase examined reinstatement of extinguished cocaine self-administration followed by a priming injection of cocaine (20.0mg/kg, intraperitoneal (I.P.)) in combination with the various KOPr agonists. Cocaine-induced drug-seeking was attenuated by pretreatment with U69593 (0.3mg/kg, subcutaneous (S.C.)), U50488H (30.0mg/kg, I.P.), SPR (1.0, 3.0mg/kg, I.P.) and Sal A (0.3, 1.0mg/kg, I.P.). Sal A (0.3, 1.0mg/kg, I.P.) had no effect on operant responding to obtain sucrose reinforcement or on cocaine-induced hyperactivity. These findings show that Sal A, like other traditional KOPr agonists attenuates cocaine-induced drug-seeking behavior.

Citing Articles

Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys.

Huskinson S, Platt D, Smith Z, Doyle W, Zamarripa C, Dunaway K Drug Alcohol Depend. 2023; 252:110953.

PMID: 37734282 PMC: 10615792. DOI: 10.1016/j.drugalcdep.2023.110953.


The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

van de Wetering R, Ewald A, Welsh S, Kornberger L, Williamson S, McElroy B Molecules. 2023; 28(12).

PMID: 37375403 PMC: 10304272. DOI: 10.3390/molecules28124848.


Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders.

Cichon J, Liu R, Le H Transl Perioper Pain Med. 2022; 9(2):452-457.

PMID: 35959414 PMC: 9364973.


The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Dalefield M, Scouller B, Bibi R, Kivell B Front Pharmacol. 2022; 13:837671.

PMID: 35795569 PMC: 9251383. DOI: 10.3389/fphar.2022.837671.


Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.

Zhou Y, Freeman K, Setola V, Cao D, Kaski S, Kreek M Handb Exp Pharmacol. 2021; 271:137-162.

PMID: 33834276 PMC: 9249371. DOI: 10.1007/164_2021_443.


References
1.
Gray A, Rawls S, Shippenberg T, McGinty J . The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J Neurochem. 1999; 73(3):1066-74. DOI: 10.1046/j.1471-4159.1999.0731066.x. View

2.
Schenk S, Partridge B, Shippenberg T . Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology (Berl). 2000; 151(1):85-90. DOI: 10.1007/s002130000476. View

3.
McLaughlin J, Li S, Valdez J, Chavkin T, Chavkin C . Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology. 2005; 31(6):1241-8. PMC: 2096774. DOI: 10.1038/sj.npp.1300872. View

4.
Negus S, Mello N, Portoghese P, Lin C . Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther. 1997; 282(1):44-55. View

5.
de Wit H, Stewart J . Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl). 1981; 75(2):134-43. DOI: 10.1007/BF00432175. View